Related Experiment Video
Updated: Aug 15, 2025

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells
Published on: June 12, 2017
The Importance of mTORC1-Autophagy Axis for Skeletal Muscle Diseases
Xujun Han1, Kah Yong Goh1, Wen Xing Lee1
1Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, 8 College Road, Singapore 169857, Singapore.
Abstract:
The mechanistic target of rapamycin (mTOR) complex 1, mTORC1, integrates nutrient and growth factor signals with cellular responses and plays critical roles in regulating cell growth, proliferation, and lifespan. mTORC1 signaling has been reported as a central regulator of autophagy by modulating almost all aspects of the autophagic process, including initiation, expansion, and termination. An increasing number of studies suggest that mTORC1 and autophagy are critical for the physiological function of skeletal muscle and are involved in diverse muscle diseases. Here, we review recent insights into the essential roles of mTORC1 and autophagy in skeletal muscles and their implications in human muscle diseases. Multiple inhibitors targeting mTORC1 or autophagy have already been clinically approved, while others are under development. These chemical modulators that target the mTORC1/autophagy pathways represent promising potentials to cure muscle diseases.
Insights
Mechanistic target of rapamycin complex 1 (mTORC1) and autophagy are crucial for skeletal muscle health and disease. Targeting these pathways with new drugs shows promise for treating muscle disorders.
Area of Science:
- Cell Biology
- Physiology
- Molecular Medicine
Background:
- Mechanistic target of rapamycin (mTOR) complex 1 (mTORC1) is a key regulator of cellular processes, integrating nutrient and growth factor signals.
- mTORC1 signaling critically influences cell growth, proliferation, and lifespan.
- Autophagy, a cellular degradation process, is tightly regulated by mTORC1.
Purpose of the Study:
- To review the essential roles of mTORC1 and autophagy in skeletal muscle physiology.
- To discuss the involvement of mTORC1 and autophagy in various human muscle diseases.
- To explore the therapeutic potential of targeting mTORC1/autophagy pathways for muscle disorders.
Main Methods:
- Literature review of recent studies on mTORC1 and autophagy in skeletal muscle.
- Analysis of the molecular mechanisms linking mTORC1, autophagy, and muscle function.
- Examination of clinical data and drug development for mTORC1 and autophagy inhibitors.
Main Results:
- mTORC1 and autophagy are vital for normal skeletal muscle function.
- Dysregulation of mTORC1 and autophagy is implicated in the pathogenesis of diverse muscle diseases.
- Existing and developing inhibitors targeting mTORC1 or autophagy show therapeutic potential.
Conclusions:
- mTORC1 and autophagy play indispensable roles in skeletal muscle health and disease.
- Targeting the mTORC1/autophagy axis offers a promising therapeutic strategy for human muscle diseases.
- Further research into these pathways could lead to novel treatments for debilitating muscle conditions.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Satellite Stem Cells and Muscular Dystrophy
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...

